Company profile
Cognito Therapeutics
Biomarker & Diagnostics Providers · Cambridge, United States
About the company
Cambridge-based neurotechnology company developing non-invasive neuromodulation therapeutics for neurodegenerative diseases, with Spectris AD as its lead Alzheimer's disease program.
Official links
Explore the full company profile
Explore company Access the complete profile and structured research in the Explorer with eligible account access.